The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MLN | -73.8% | -93.69% | -42.45% | -91% |
| S&P | +12.9% | +73.65% | +11.66% | +189% |
Enzyme (MLN) is an Ethereum-based token for the Enzyme platform, designed for on-chain asset management. MLN is used to pay platform usage fees and incentivize participants. The Enzyme platform is a DeFi protocol that enables users to establish, manage, and invest in decentralized on-chain investment vehicles. It was created by Mona El Isa and Reto Trinkler to simplify and democratize finance. The MLN token plays a crucial role in maintaining and operating the Enzyme platform, with some fees stored in the Enzyme treasury to fund future development.
No news articles found for Enzyme.
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.